CUMBRE PHARMACEUTICALS
Similar Organizations
Akela Pharmaceuticals
Akela Pharmaceuticals is a Medical company.
Angstorm Pharmaceuticals
Angstorm Pharmaceuticals is a Health Care company.
Deuteria Pharmaceuticals,Inc.
Deuteria Pharmaceuticals,Inc. is a Health Care company.
Hoechst Roussel Pharmaceuticals
Hoechst Roussel Pharmaceuticals is a Health Care company.
ICI Pharmaceuticals
ICI Pharmaceuticals is a Health Care company.
Merrell Dow Pharmaceuticals
Merrell Dow Pharmaceuticals is a Health Care company.
More informations about "Cumbre Pharmaceuticals"
Cumbre Company Profile | Management and Employees List
Cumbre Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focusing on developing anti-infective products for the treatment of serious and life-threatening bacterial infections, โฆSee details»
Cumbre Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical โฆ
Explore Cumbre Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 16 literature, Disease Domain:Infectious Diseases, Technology Platform:Small โฆSee details»
Cumbre Pharmaceuticals - Products, Competitors, Financials, โฆ
Cumbre Pharmaceuticals is a Dallas, Texas-based Healthcare company. Use the CB Insights Platform to explore Cumbre Pharmaceuticals's full profile. Cumbre Pharmaceuticals - โฆSee details»
Cumbre - Products, Competitors, Financials, Employees, โฆ
Cumbre is a Healthcare/Pharmaceuticals / Drugs company based in Dallas, Texas. Use the CB Insights Platform to explore Cumbre's full profile. Cumbre - Products, Competitors, Financials, โฆSee details»
Cumbre Pharmaceuticals - VentureRadar
Find out more about Cumbre Pharmaceuticals including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena Belgium n/a Ardena is a fully integrated โฆSee details»
Cumbre Pharmaceuticals dissolves - Dallas Business Journal
May 11, 2009 Cumbre Pharmaceuticals defunct despite promise of new antibiotic development. By Joyce Tsai โ Staff writer . May 10, 2009 Updated May 8, 2009, 7:00am CDT. Cumbre โฆSee details»
Cumbre Pharmaceuticals - Crunchbase
Cumbre Pharmaceuticals is a Health Care company. Start Free Trial . Chrome ExtensionSee details»
Cumbre Pharmaceuticals, Inc.:Company Profile & Technical โฆ
Cumbre Pharmaceuticals, Inc. is headquartered in United States Texas. Cumbre Pharmaceuticals, Inc. was founded in 2001. Cumbre Pharmaceuticals, Inc. has a total of 8 โฆSee details»
Cumbre Pharmaceuticals, Inc. (Cumbre Pharmaceuticals, Inc.) - ่ฏ โฆ
ไบ่งฃCumbre Pharmaceuticals, Inc. (Cumbre Pharmaceuticals, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็16็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:ๆๆ๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ่ฏ๏ผ่ฏ โฆSee details»
Cumbre Pharmaceuticals Inc. - US Patent and Trademark Search
Jun 12, 2008 Cumbre Pharmaceuticals inc: uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and โฆSee details»
Cumbre Pharmaceuticals And Global Alliance For TB Drug
Sep 27, 2006 DALLAS & NEW YORK--(BUSINESS WIRE)--Cumbre Pharmaceuticals Inc, a Dallas-based biopharmaceutical company, and the Global Alliance for TB Drug Development โฆSee details»
Cumbre Pharmaceuticals, Inc.:Board โฆ
Discovery Company profile page for Cumbre Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Research programme: antibacterials - Cumbre Pharmaceuticals
Dec 29, 2009 Cumbre Pharmaceuticals was a biopharmaceutical company that was investigating RNA polymerase inhibitors as potential therapies for bacterial infections. โฆSee details»
Cumbre Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Cumbre Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Cumbre Pharmaceuticals's post-money valuation and revenue.See details»
CBR703 - Drug Targets, Indications, Patents - Synapse
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
CBR-2096 - Drug Targets, Indications, Patents - Synapse
CBR-2096, Initially developed by Cumbre Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Infectious Diseases. ... Originator Organization. โฆSee details»
Cumbre Pharmaceuticals, Inc.:Funding,Funding Rounds,Funding โฆ
Discovery Company profile page for Cumbre Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Patents Assigned to Cumbre Pharmaceuticals Inc.
Nov 12, 2008 Abstract: Rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms are claimed in this invention. The inventive rifamycin โฆSee details»
FDA to pharmaceutical companies: Certain studies conducted by โฆ
5 days ago FDA has identified significant data integrity and study conduct concerns with bioequivalence and bioavailability studies conducted by Raptim Research Pvt. Ltd., a contract โฆSee details»
Cumbre Pharmaceuticals, Inc.:Financial,Market Cap,Revenue
Discovery Company profile page for Cumbre Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»